Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis

New Onset of Uveitis During Anti-Tumor Necrosis Factor Treatment for Rheumatic Diseases

(2011) Daniel Wendling et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Current therapeutic approaches to autoimmune chronic uveitis in children

(2010) Gabriele Simonini et al.   AUTOIMMUNITY REVIEWS

Recent developments in the treatment of uveitis: an update

(2009) Fiona Lyon et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Switching biologic agents for uveitis

(2009) N Dhingra et al.   EYE

Retrospective analysis of children with uveitis treated with infliximab

(2008) Ilknur Tugal-Tutkun et al.   JOURNAL OF AAPOS

Loss of efficacy during long-term infliximab therapy for sight-threatening childhood uveitis

(2008) G. Simonini et al.   RHEUMATOLOGY